{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:44:13Z","timestamp":1764603853212,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ijbiomac.2022.01.175","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T19:55:42Z","timestamp":1643745342000},"page":"661-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Microparticles entrapping pneumococcal protein SP0845 show improved immunogenicity and temperature stability"],"prefix":"10.1016","volume":"203","author":[{"given":"Rahul","family":"Ahuja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Shelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jairam","family":"Meena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amulya K.","family":"Panda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2019","series-title":"W.H.O, Reported Cases of Selected Vaccine Preventable Diseases (VPDs) (2019c)","key":"10.1016\/j.ijbiomac.2022.01.175_bb0005"},{"author":"Organization","key":"10.1016\/j.ijbiomac.2022.01.175_bb0010"},{"key":"10.1016\/j.ijbiomac.2022.01.175_bb0015","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3389\/fmicb.2020.01526","article-title":"Impact of vaccines; health, economic and social perspectives","volume":"11","author":"Rodrigues","year":"2020","journal-title":"Front. Microbiol."},{"issue":"1645","key":"10.1016\/j.ijbiomac.2022.01.175_bb0020","article-title":"The contribution of vaccination to global health: past, present and future","volume":"369","author":"Greenwood","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2022.01.175_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.1964.03070140047006","article-title":"Paralytic disease associated with oral polio vaccines","volume":"190","author":"Henderson","year":"1964","journal-title":"JAMA"},{"issue":"48","key":"10.1016\/j.ijbiomac.2022.01.175_bb0030","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"Lindsey","year":"2008","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.01.175_bb0035","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1586\/erv.09.106","article-title":"Intussusception and rotavirus vaccination: a review of the available evidence","volume":"8","author":"Patel","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2022.01.175_bb0040","first-page":"45","article-title":"Inactivated viral vaccines","author":"Sanders","year":"2014","journal-title":"Vaccine Analysis: Strategies, Principles, and Control"},{"key":"10.1016\/j.ijbiomac.2022.01.175_bb0045","first-page":"29","article-title":"The cutter incident. Poliomyelitis following formaldehyde- inactivated poliovirus vaccination in the United States during the spring of 1955. Ii. Relationship of poliomyelitis to cutter vaccine","volume":"78","author":"Nathanson","year":"1963","journal-title":"Am. J. Hyg."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.01.175_bb0050","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4161\/hv.6.6.11562","article-title":"New insights for development of a safe and protective RSV vaccine","volume":"6","author":"Blanco","year":"2010","journal-title":"Hum. Vacc."},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.01.175_bb0055","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1586\/erv.11.120","article-title":"Respiratory syncytial virus vaccine development","volume":"10","author":"Hurwitz","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.01.175_bb0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.01.175_bb0065","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1542\/peds.108.5.e81","article-title":"Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the italian experience","volume":"108","author":"Salmaso","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijbiomac.2022.01.175_bb0070","series-title":"Case Studies in Public Health","first-page":"443","article-title":"Chapter 19 - Maurice Hilleman: creator of vaccines that changed the world","author":"Tulchinsky","year":"2018"},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.01.175_bb0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1179\/2047773214Y.0000000162","article-title":"Bexsero\u00ae chronicle","volume":"108","author":"Vernikos","year":"2014","journal-title":"Pathog. Glob. Health"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.01.175_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41541-020-0195-4","article-title":"Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology","volume":"5","author":"Garcea","year":"2020","journal-title":"npj Vaccines"},{"issue":"9693","key":"10.1016\/j.ijbiomac.2022.01.175_bb0085","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"issue":"9875","key":"10.1016\/j.ijbiomac.2022.01.175_bb0090","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(13)60222-6","article-title":"Global burden of childhood pneumonia and diarrhoea","volume":"381","author":"Walker","year":"2013","journal-title":"Lancet"},{"year":"2020","series-title":"The Pneumonia and Diarrhea Progress Report","author":"JHBSPH","key":"10.1016\/j.ijbiomac.2022.01.175_bb0095"},{"key":"10.1016\/j.ijbiomac.2022.01.175_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1742-4755-11-82","article-title":"UNICEF report: enormous progress in child survival but greater focus on newborns urgently needed","volume":"11","author":"Wardlaw","year":"2014","journal-title":"Reprod. Health"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.01.175_bb0105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.chest.2020.10.066","article-title":"What does severe acute respiratory syndrome coronavirus 2 mean for global pneumonia prevention, diagnosis, and treatment?","volume":"159","author":"Awasthi","year":"2021","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.01.175_bb0110","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1592\/phco.2005.25.9.1193","article-title":"Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention","volume":"25","author":"Bridy-Pappas","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.01.175_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118154","article-title":"Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo","volume":"10","author":"Saxena","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.01.175_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro","year":"2011","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.01.175_bb0125","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s00705-018-3856-0","article-title":"Nanoparticle vaccines against viral infections","volume":"163","author":"Sulczewski","year":"2018","journal-title":"Arch. Virol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.01.175_bb0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.01.175_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jbm.820050207","article-title":"A new absorbable suture","volume":"5","author":"Frazza","year":"1971","journal-title":"J. Biomed. Mater. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.01.175_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/14760584.2.2.269","article-title":"Microparticles as vaccine adjuvants and delivery systems","volume":"2","author":"O'Hagan","year":"2003","journal-title":"Expert Rev. Vaccines"},{"issue":"18","key":"10.1016\/j.ijbiomac.2022.01.175_bb0145","first-page":"511","article-title":"Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015","volume":"55","year":"2006"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.01.175_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s13167-010-0001-x","article-title":"Drug delivery systems: advanced technologies potentially applicable in personalized treatments","volume":"1","author":"Coelho","year":"2010","journal-title":"EPMA J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.01.175_bb0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12951-021-00812-9","article-title":"Development of a chitosan-modified PLGA nanoparticle vaccine for protection against Escherichia coli K1 caused meningitis in mice","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2022.01.175_bb0160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejphar.2014.12.004","article-title":"Biodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens","volume":"747","author":"Anugraha","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2022.01.175_bb0165","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.ijbiomac.2020.07.056","article-title":"Effect of N-terminal poly histidine-tag on immunogenicity of Streptococcus pneumoniae surface protein SP0845","volume":"163","author":"Singh","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.01.175_bb0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2005.05.028","article-title":"Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles","volume":"301","author":"Katare","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.01.175_bb0175","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/02652048.2010.489974","article-title":"Controlled release of bioactive recombinant human growth hormone from PLGA microparticles","volume":"27","author":"Rafi","year":"2010","journal-title":"J. Microencapsul."},{"issue":"17","key":"10.1016\/j.ijbiomac.2022.01.175_bb0180","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.vaccine.2006.01.066","article-title":"Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum","volume":"24","author":"Katare","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.01.175_bb0185","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1023\/A:1012180707283","article-title":"Rational design of stable lyophilized protein formulations: some practical advice","volume":"14","author":"Carpenter","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2022.01.175_bb0190","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejpb.2015.05.009","article-title":"Development of a highly thermostable, adjuvanted human papillomavirus vaccine","volume":"94","author":"Hassett","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"27","key":"10.1016\/j.ijbiomac.2022.01.175_bb0195","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1016\/j.biomaterials.2009.05.075","article-title":"Memory antibody response from antigen loaded polymer particles and the effect of antigen release kinetics","volume":"30","author":"Kanchan","year":"2009","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.01.175_bb0200","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.01.175_bb0205","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.01.175_bb0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejps.2009.05.009","article-title":"Role of alum in improving the immunogenicity of biodegradable polymer particle entrapped antigens","volume":"38","author":"Kanchan","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.01.175_bb0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12249-018-1254-2","article-title":"Stability of vaccines","volume":"20","author":"Dumpa","year":"2019","journal-title":"AAPS PharmSciTech"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022001982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022001982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:25:45Z","timestamp":1758878745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":43,"alternative-id":["S0141813022001982"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.175","relation":{},"ISSN":["0141-8130"],"issn-type":[{"type":"print","value":"0141-8130"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microparticles entrapping pneumococcal protein SP0845 show improved immunogenicity and temperature stability","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}